← Back to screener

Chemours Co CC

Rank #2131 · NYSE · $2.0B market cap
Audited by PricewaterhouseCoopers LLP, no going-concern flag in the latest filing.
Score
32.7
P/E
-8.0
P/B
2.82
ROE
-35.1%
Op. Margin
–%
Debt Ratio
1043%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆
Weak

P/E -8.0x, P/B 2.82x. Ranks in the top 68% of the universe.

Profitability ★☆☆☆☆
Poor

ROE -35.1%. Ranks in the top 86% of the universe.

Safety ★☆☆☆☆
Poor

Debt ratio 1043%. Ranks in the top 91% of the universe. Above 200% signals meaningful leverage risk.

Growth ★☆☆☆☆
Poor

Revenue decline of 11.0% year over year. Ranks in the top 85% of the universe.

Valuation is the relative strength · Profitability is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2015––$0.4B$3.7B–62
2016$6.4B–$0.4B$0.1B–4895
2017$5.7B–$-0.1B$0.1B–5956
2018$5.4B–$0.0B$0.9B–747
2019$6.2B–$0.7B$1.0B–625
2020$6.6B–$1.0B$0.7B–953
2021$5.5B–$-0.1B$0.8B–771
2022$5.0B–$0.2B$1.1B–598
2023$6.3B–$0.6B$1.1B–590
2024$6.8B–$0.6B$0.7B–1019
2025$6.1B–$-0.3B$0.7B–1043

← See the full screener